The company's Singapore subsidiary has entered a SPA to acquire 10 per cent stake a biotech start-up Inipharm Incorporated, in the US.

Zydus Cadila, a global pharmaceutical company, informed in a press release that the company has received USFDA approvals for Lansoprazole Tablets and Linagliptin Tablets.

Investors mainly depend on the mutual fund distributors for investment advice, but with the market maturing now there are advisors who just provide advice rather than sell MF products. Let us understand how both of them work so that you can make an informed decision.

Following stocks are close to their 52-week low as at 12.38 p.m. on November 29, 2018.

The markets on November 29, 2018 opened gap up. BSE Sensex is trading at 36,073.22, up by 356.27 points and the Nifty is trading at 10,829.40, up by 100.55 points. 

Indian equity market showed rare resilience on rollover day for the December series on Thursday. Metals, OMCs, FMCG and media stocks powered the upward rally. Index heavyweight Reliance Industries supported the uptick.

Overall volumes in futures & options currently stand at 1.63 crore contracts with a turnover of Rs. 9,81,152.54 crore.

Overall volumes in futures & options currently stand at 1.63 crore contracts with a turnover of Rs. 9,81,152.54 crore.

Nifty has strong resistance placed in the region of 10,740-10,780. Today being November F&O expiry, we expect volatility to remain embedded in the session. Stocks in news: Persistent Systems, Bharat Financial, Mercator, Sical Logistics, Mawana Sugars, Indoco Remedies, Cosmo Films, TCS and Spice Jet.

The domestic benchmark indices are expected to witness a blistering start to the November F&O expiry day as global markets are cheering the dovish stance taken by Fed Chief Jerome Powell and the positive effect is likely to rub-off on Indian markets too. The SGX Nifty Index Future was trading higher by 91 points  above the 10,800 mark.